Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Endothelin-1 as a mediator and potential biomarker for interferon induced pulmonary toxicity.

George PM, Cunningham ME, Galloway-Phillipps N, Badiger R, Alazawi W, Foster GR, Mitchell JA.

Pulm Circ. 2012 Oct;2(4):501-4. doi: 10.4103/2045-8932.105039.

2.

Effect of different interferonα2 preparations on IP10 and ET-1 release from human lung cells.

Badiger R, Mitchell JA, Gashaw H, Galloway-Phillipps NA, Foser S, Tatsch F, Singer T, Hansel TT, Manigold T.

PLoS One. 2012;7(10):e46779. doi: 10.1371/journal.pone.0046779. Epub 2012 Oct 8.

3.
4.

Endothelin: systemic arterial and pulmonary effects of a new peptide with potent biologic properties.

Lüscher TF.

Am Rev Respir Dis. 1992 Nov;146(5 Pt 2):S56-60. Review.

PMID:
1332560
5.

Endothelin-1 and IP3 induced Ca2+ sparks in pulmonary arterial smooth muscle cells.

Zhang WM, Lin MJ, Sham JS.

J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S121-4.

PMID:
15838259
6.

Pharmacology and therapeutic potential of interferons.

George PM, Badiger R, Alazawi W, Foster GR, Mitchell JA.

Pharmacol Ther. 2012 Jul;135(1):44-53. doi: 10.1016/j.pharmthera.2012.03.006. Epub 2012 Mar 28. Review.

PMID:
22484806
7.

Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

Stewart DJ, Levy RD, Cernacek P, Langleben D.

Ann Intern Med. 1991 Mar 15;114(6):464-9.

PMID:
1994793
8.

Viral Toll Like Receptor activation of pulmonary vascular smooth muscle cells results in endothelin-1 generation; relevance to pathogenesis of pulmonary arterial hypertension.

George PM, Badiger R, Shao D, Edwards MR, Wort SJ, Paul-Clark MJ, Mitchell JA.

Biochem Biophys Res Commun. 2012 Oct 5;426(4):486-91. doi: 10.1016/j.bbrc.2012.08.106. Epub 2012 Aug 28.

PMID:
22960172
9.

[Hepatitis C, interferon a and depression: main physiopathologic hypothesis].

Vignau J, Karila L, Costisella O, Canva V.

Encephale. 2005 May-Jun;31(3):349-57. Review. French.

PMID:
16142050
10.

Endothelin receptor blockade prevents the rise in pulmonary vascular resistance after cardiopulmonary bypass in lambs with increased pulmonary blood flow.

Petrossian E, Parry AJ, Reddy VM, Akkersdijk GP, McMullan DM, Thompson L, Hendricks-Munoz KD, Hallak H, Hanley FL, Fineman JR.

J Thorac Cardiovasc Surg. 1999 Feb;117(2):314-23.

11.

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ.

N Engl J Med. 1993 Jun 17;328(24):1732-9.

12.

Anti-hepatitis C virus activity of albinterferon alfa-2b in cell culture.

Liu C, Zhu H, Subramanian GM, Moore PA, Xu Y, Nelson DR.

Hepatol Res. 2007 Nov;37(11):941-7. Epub 2007 Jun 15.

PMID:
17573950
13.

Endothelin-1 in acute lung injury and the adult respiratory distress syndrome.

Langleben D, DeMarchie M, Laporta D, Spanier AH, Schlesinger RD, Stewart DJ.

Am Rev Respir Dis. 1993 Dec;148(6 Pt 1):1646-50.

PMID:
8256914
14.

Synergistic induction of endothelin-1 by tumor necrosis factor alpha and interferon gamma is due to enhanced NF-kappaB binding and histone acetylation at specific kappaB sites.

Wort SJ, Ito M, Chou PC, Mc Master SK, Badiger R, Jazrawi E, de Souza P, Evans TW, Mitchell JA, Pinhu L, Ito K, Adcock IM.

J Biol Chem. 2009 Sep 4;284(36):24297-305. doi: 10.1074/jbc.M109.032524. Epub 2009 Jul 10.

15.

Role of endothelin in the control of peripheral vascular tone in human hypertension.

Taddei S, Virdis A, Ghiadoni L, Sudano I, Magagna A, Salvetti A.

Heart Fail Rev. 2001 Dec;6(4):277-85. Review.

PMID:
11447302
16.
17.

Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: modulation by peroxisome proliferator-activated receptor-gamma agonists.

Antonelli A, Ferrari SM, Fallahi P, Ghiri E, Crescioli C, Romagnani P, Vitti P, Serio M, Ferrannini E.

Cytokine. 2010 Jun;50(3):260-7. doi: 10.1016/j.cyto.2010.01.009. Epub 2010 Mar 17.

PMID:
20299237
18.

Endothelin receptor antagonists for pulmonary arterial hypertension.

Liu C, Chen J, Gao Y, Deng B, Liu K.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD004434. doi: 10.1002/14651858.CD004434.pub5. Review.

PMID:
23450552
19.

Pulmonary arterial hypertension in patients treated with interferon.

Savale L, Sattler C, Günther S, Montani D, Chaumais MC, Perrin S, Jaïs X, Seferian A, Jovan R, Bulifon S, Parent F, Simonneau G, Humbert M, Sitbon O.

Eur Respir J. 2014 Dec;44(6):1627-34. doi: 10.1183/09031936.00057914. Epub 2014 Oct 16. Erratum in: Eur Respir J. 2015 Dec;46(6):1854.

20.

Endothelin receptor antagonism in pulmonary arterial hypertension--a role for selective ET(A) inhibition?

Jacobs A, Preston IR, Gomberg-Maitland M.

Curr Med Res Opin. 2006 Dec;22(12):2567-74. Review.

PMID:
17166339

Supplemental Content

Support Center